Anti-RGDSR/ RGL4/ Rgr monoclonal antibody
Anti-RGDSR/ RGL4/ Rgr antibody for FACS & in-vivo assay
Go to RGL4/RGL4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP2595-Ab-1/ GM-Tg-hg-MP2595-Ab-2 | Anti-Human RGL4 monoclonal antibody | Human |
GM-Tg-rg-MP2595-Ab-1/ GM-Tg-rg-MP2595-Ab-2 | Anti-Rat RGL4 monoclonal antibody | Rat |
GM-Tg-mg-MP2595-Ab-1/ GM-Tg-mg-MP2595-Ab-2 | Anti-Mouse RGL4 monoclonal antibody | Mouse |
GM-Tg-cynog-MP2595-Ab-1/ GM-Tg-cynog-MP2595-Ab-2 | Anti-Cynomolgus/ Rhesus macaque RGL4 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP2595-Ab-1/ GM-Tg-felg-MP2595-Ab-2 | Anti-Feline RGL4 monoclonal antibody | Feline |
GM-Tg-cang-MP2595-Ab-1/ GM-Tg-cang-MP2595-Ab-2 | Anti-Canine RGL4 monoclonal antibody | Canine |
GM-Tg-bovg-MP2595-Ab-1/ GM-Tg-bovg-MP2595-Ab-2 | Anti-Bovine RGL4 monoclonal antibody | Bovine |
GM-Tg-equg-MP2595-Ab-1/ GM-Tg-equg-MP2595-Ab-2 | Anti-Equine RGL4 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP2595-Ab-1/ GM-Tg-hg-MP2595-Ab-2; GM-Tg-rg-MP2595-Ab-1/ GM-Tg-rg-MP2595-Ab-2; GM-Tg-mg-MP2595-Ab-1/ GM-Tg-mg-MP2595-Ab-2; GM-Tg-cynog-MP2595-Ab-1/ GM-Tg-cynog-MP2595-Ab-2; GM-Tg-felg-MP2595-Ab-1/ GM-Tg-felg-MP2595-Ab-2; GM-Tg-cang-MP2595-Ab-1/ GM-Tg-cang-MP2595-Ab-2; GM-Tg-bovg-MP2595-Ab-1/ GM-Tg-bovg-MP2595-Ab-2; GM-Tg-equg-MP2595-Ab-1/ GM-Tg-equg-MP2595-Ab-2 |
Products Name | Anti-RGL4 monoclonal antibody |
Format | mab |
Target Name | RGL4 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-RGL4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species RGDSR/ RGL4/ Rgr VLP (virus-like particle) (Products Developing) |
Target information
Target ID | GM-MP2595 |
Target Name | RGL4 |
Gene ID | 266747 |
Gene Symbol and Synonyms | RGL4,Rgr |
Uniprot Accession | Q8IZJ4 |
Uniprot Entry Name | RGDSR_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000159496 |
Target Classification | N/A |
The target: RGL4, gene name: RGL4, also named as Rgr. This oncogene encodes a protein similar to guanine nucleotide exchange factor Ral guanine dissociation stimulator. Increased expression of this gene leads to translocation of the encoded protein to the cell membrane. The encoded protein can activate several pathways, including the Ras-Raf-MEK-ERK cascade. [provided by RefSeq, Jul 2016].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.